Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy.

Lai CH, Irvin SC, Salazar-Fontana LI, Grimaldi C, Gorovits B, Xu Y, Partridge MA

Open source

DOI
10.1208/s12248-026-01303-1
Published
2026 Sep 9
Container
The AAPS journal
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12248-026-01303-1,
  title = {Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy.},
  author = {Lai CH and Irvin SC and Salazar-Fontana LI and Grimaldi C and Gorovits B and Xu Y and Partridge MA},
  year = {2026},
  journal = {The AAPS journal},
  doi = {10.1208/s12248-026-01303-1},
  url = {https://doi.org/10.1208/s12248-026-01303-1}
}

RIS

TY  - JOUR
TI  - Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy.
AU  - Lai CH
AU  - Irvin SC
AU  - Salazar-Fontana LI
AU  - Grimaldi C
AU  - Gorovits B
AU  - Xu Y
AU  - Partridge MA
PY  - 2026
JO  - The AAPS journal
DO  - 10.1208/s12248-026-01303-1
UR  - https://doi.org/10.1208/s12248-026-01303-1
ER  - 

APA

CH, L., SC, I., LI, S., C, G., B, G., Y, X., & MA, P. (2026). Immunogenicity in Approved Adeno-Associated Virus-Based Gene Therapies: A Framework for a Tailored Assessment Strategy.. The AAPS journal. https://doi.org/10.1208/s12248-026-01303-1

Source records